LigaChem Biosciences Inc (141080)

KOSDAQ

Currency in KRW

106,500

+900(+0.85%)

Closed08:29:59

Fair Value

Day's Range

101,600

108,000

52 wk Range

45,450

143,600

141080 Income Statement

Featured here, the Income Statement (earnings report) for LigaChem Biosciences Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

57,500.14

32,157.01

33,412.04

34,145.64

Total Revenues Growth

+127.81%

-44.07%

+3.9%

+2.2%

Cost Of Revenues

22,689.05

14,459.45

15,563.35

16,348.33

Gross Profit

34,811.08

17,697.56

17,848.69

17,797.31

Gross Profit Growth

+489.18%

-49.16%

+0.85%

-0.29%

Gross Profit Margin %

60.54%

55.03%

53.42%

52.12%

Other Operating Expenses, Total

26,394.24

45,404.22

68,223.79

98,619.66

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+20.6%	+72.02%	+50.26%	+44.55%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	16,711.21	39,071.09	51,109.7	79,608.77
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	7,976.68	4,707.05	15,437.21	17,247.55
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-

Operating Income

8,416.84

-27,706.66

-50,375.1

-80,822.34

Operating Income Growth

+152.68%

-429.18%

-81.82%

-60.44%

EBIT Margin %

14.64%

-86.16%

-150.77%

-236.7%

Net Interest Expenses

1,515.85

832.55

3,981.34

5,279.8

Net Interest Expenses Growth

+406.46%

-45.08%

+378.21%

+32.61%

Interest Expense, Total

-25.8

-68.77

-285.75

-528.26

Interest And Investment Income

1,541.65

901.31

4,267.09

5,808.06

Other Non Operating Expenses, Total

-819.77

6,042.47

997.88

6,871.04

EBT, Excl. Unusual Items

9,112.91

-20,831.65

-45,395.88

-68,671.5

Gain (Loss) On Sale Of Assets

-0.41

-177.86

1.13

37.83

Other Unusual Items, Total

-

-

-239.68

-260.19

EBT, Incl. Unusual Items

13,101.52

-20,523.03

-47,722.62

-75,746.56

EBT, Incl. Unusual Items Growth

+149.58%

-256.65%

-132.53%

-58.72%

EBT, Incl. Unusual Items Margin

22.79%

-63.82%

-142.83%

-221.83%

Income Tax Expense

626.01

2,868.2

-2,630.82

-2,042.99

Net Income to Company

12,475.51

-23,391.23

-45,091.79

-73,703.57

Minority Interest

1,110.62

-

-

-

Net Income

13,586.13

-23,391.23

-45,091.79

-73,703.57

Net Income Growth

+152.72%

-272.17%

-92.77%

-63.45%

Net Income Margin %

23.63%

-72.74%

-134.96%

-215.85%

Preferred Dividend and Other Adjustments

-

-

-

-

Net Income to Common Excl. Extra Items

13,586.13

-23,391.23

-45,091.79

-73,703.57

Basic EPS - Continuing Operations

640.57

-969.59

-1,609.47

-2,594.83

Basic EPS - Continuing Operations Growth

+152.39%

-251.36%

-66%

-61.22%

Diluted EPS - Continuing Operations

566

-970

-1,609.47

-2,595

Diluted EPS - Continuing Operations Growth

+146.29%

-271.38%

-65.92%

-61.23%

Basic Weighted Average Shares Outstanding

21.21

24.12

28.02

28.4

Diluted Weighted Average Shares Outstanding

24.01

24.12

28.02

28.4

Dividend Per Share

-

-

-

-

Dividend Per Share Growth

-

-

-

-

EBITDA

12,281.61

-24,657.52

-46,257.09

-76,150.4

EBITDA Growth

+193.06%

-300.77%

-87.6%

-64.62%

EBITDA Margin %

21.36%

-76.68%

-138.44%

-223.02%

EBIT

8,416.84

-27,706.66

-50,375.1

-80,822.34

* In Millions of KRW (except for per share items)